Exploiting the unique properties of nanobodies: enhancing therapeutics, drug delivery, and targeted diagnostics

Nanobodies (Nbs) are genetically engineered single domain antibodies derived from heavy chain-only antibodies (HcAbs) found in camelid species. These monomeric antibody fragments are smaller and have lower molecular weight compared with conventional antibodies, while retaining full antigen-binding s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Blank, Lisa (VerfasserIn) , Pander, Giulia (VerfasserIn) , Mühlberg, Eric (VerfasserIn) , Mier, Walter (VerfasserIn) , Uhl, Philipp (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: December 2025
In: Drug discovery today
Year: 2025, Jahrgang: 30, Heft: 12, Pages: 1-14
ISSN:1878-5832
DOI:10.1016/j.drudis.2025.104524
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.drudis.2025.104524
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1359644625002375
Volltext
Verfasserangaben:Lisa Blank, Giulia Pander, Eric Mühlberg, Walter Mier, Philipp Uhl

MARC

LEADER 00000naa a2200000 c 4500
001 1950175014
003 DE-627
005 20260126092502.0
007 cr uuu---uuuuu
008 260126s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.drudis.2025.104524  |2 doi 
035 |a (DE-627)1950175014 
035 |a (DE-599)KXP1950175014 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Blank, Lisa  |e VerfasserIn  |0 (DE-588)1387967177  |0 (DE-627)1950175340  |4 aut 
245 1 0 |a Exploiting the unique properties of nanobodies  |b enhancing therapeutics, drug delivery, and targeted diagnostics  |c Lisa Blank, Giulia Pander, Eric Mühlberg, Walter Mier, Philipp Uhl 
264 1 |c December 2025 
300 |b Illustrationen 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 1. November 2025, Artikelversion: 17. November 2025 
500 |a Gesehen am 26.01.2026 
520 |a Nanobodies (Nbs) are genetically engineered single domain antibodies derived from heavy chain-only antibodies (HcAbs) found in camelid species. These monomeric antibody fragments are smaller and have lower molecular weight compared with conventional antibodies, while retaining full antigen-binding specificity, endowing them with unique structural and functional properties. As in vitro diagnostics, they can aid pathogen detection and biomarker identification. In vivo, their rapid clearance and deep tissue penetration enable radio-imaging with short half-life radionuclides, reducing patient exposure. Therapeutically, Nbs are being explored for cancer, neurodegenerative, and infectious diseases. However, their short serum half-life is challenging, prompting strategies to extend circulation time without compromising their benefits. Despite these hurdles, the high specificity, low immunogenicity, and versatility of Nbs position them as promising tools across diverse applications. 
650 4 |a computational generation 
650 4 |a diagnostics 
650 4 |a imaging 
650 4 |a nanobody 
650 4 |a research applications 
650 4 |a therapeutics 
700 1 |a Pander, Giulia  |e VerfasserIn  |0 (DE-588)1276202776  |0 (DE-627)1828154032  |4 aut 
700 1 |a Mühlberg, Eric  |e VerfasserIn  |0 (DE-588)1202991130  |0 (DE-627)1687644055  |4 aut 
700 1 |a Mier, Walter  |d 1966-  |e VerfasserIn  |0 (DE-588)12029026X  |0 (DE-627)69653567X  |0 (DE-576)292141599  |4 aut 
700 1 |a Uhl, Philipp  |e VerfasserIn  |0 (DE-588)1112349391  |0 (DE-627)866420797  |0 (DE-576)476575230  |4 aut 
773 0 8 |i Enthalten in  |t Drug discovery today  |d Amsterdam [u.a.] : Elsevier Science, 1996  |g 30(2025), 12 vom: Dez., Artikel-ID 104524, Seite 1-14  |h Online-Ressource  |w (DE-627)306658348  |w (DE-600)1500337-1  |w (DE-576)259270970  |x 1878-5832  |7 nnas  |a Exploiting the unique properties of nanobodies enhancing therapeutics, drug delivery, and targeted diagnostics 
773 1 8 |g volume:30  |g year:2025  |g number:12  |g month:12  |g elocationid:104524  |g pages:1-14  |g extent:14  |a Exploiting the unique properties of nanobodies enhancing therapeutics, drug delivery, and targeted diagnostics 
856 4 0 |u https://doi.org/10.1016/j.drudis.2025.104524  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1359644625002375  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20260126 
993 |a Article 
994 |a 2025 
998 |g 1112349391  |a Uhl, Philipp  |m 1112349391:Uhl, Philipp  |d 160000  |d 160100  |e 160000PU1112349391  |e 160100PU1112349391  |k 0/160000/  |k 1/160000/160100/  |p 5  |y j 
998 |g 12029026X  |a Mier, Walter  |m 12029026X:Mier, Walter  |d 910000  |d 911400  |d 160000  |e 910000PM12029026X  |e 911400PM12029026X  |e 160000PM12029026X  |k 0/910000/  |k 1/910000/911400/  |k 0/160000/  |p 4 
998 |g 1202991130  |a Mühlberg, Eric  |m 1202991130:Mühlberg, Eric  |d 160000  |d 160100  |e 160000PM1202991130  |e 160100PM1202991130  |k 0/160000/  |k 1/160000/160100/  |p 3 
998 |g 1276202776  |a Pander, Giulia  |m 1276202776:Pander, Giulia  |d 160000  |d 160100  |d 160000  |e 160000PP1276202776  |e 160100PP1276202776  |e 160000PP1276202776  |k 0/160000/  |k 1/160000/160100/  |k 0/160000/  |p 2 
999 |a KXP-PPN1950175014  |e 4860239083 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1950175014","name":{"displayForm":["Lisa Blank, Giulia Pander, Eric Mühlberg, Walter Mier, Philipp Uhl"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"December 2025"}],"id":{"eki":["1950175014"],"doi":["10.1016/j.drudis.2025.104524"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"14 S.","noteIll":"Illustrationen"}],"language":["eng"],"title":[{"title":"Exploiting the unique properties of nanobodies","subtitle":"enhancing therapeutics, drug delivery, and targeted diagnostics","title_sort":"Exploiting the unique properties of nanobodies"}],"person":[{"display":"Blank, Lisa","given":"Lisa","role":"aut","family":"Blank"},{"display":"Pander, Giulia","family":"Pander","role":"aut","given":"Giulia"},{"role":"aut","given":"Eric","family":"Mühlberg","display":"Mühlberg, Eric"},{"display":"Mier, Walter","role":"aut","given":"Walter","family":"Mier"},{"given":"Philipp","role":"aut","family":"Uhl","display":"Uhl, Philipp"}],"relHost":[{"disp":"Exploiting the unique properties of nanobodies enhancing therapeutics, drug delivery, and targeted diagnosticsDrug discovery today","recId":"306658348","part":{"text":"30(2025), 12 vom: Dez., Artikel-ID 104524, Seite 1-14","extent":"14","volume":"30","pages":"1-14","year":"2025","issue":"12"},"origin":[{"dateIssuedKey":"1996","publisher":"Elsevier Science","dateIssuedDisp":"1996-","publisherPlace":"Amsterdam [u.a.]"}],"id":{"zdb":["1500337-1"],"issn":["1878-5832"],"eki":["306658348"]},"pubHistory":["1.1996 -"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"note":["Gesehen am 08.02.2021"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Drug discovery today","title_sort":"Drug discovery today"}]}],"note":["Online verfügbar: 1. November 2025, Artikelversion: 17. November 2025","Gesehen am 26.01.2026"]} 
SRT |a BLANKLISAPEXPLOITING2025